Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ria van Vliet"'
Autor:
Ronak Delewi, Rosanne F. Vogel, Jeroen M. Wilschut, Miguel E. Lemmert, Roberto Diletti, Ria van Vliet, Nancy W.P.L. van der Waarden, Rutger-Jan Nuis, Valeria Paradies, Dimitrios Alexopoulos, Felix Zijlstra, Gilles Montalescot, Dominick J. Angiolillo, Mitchell W. Krucoff, Pieter A. Doevendans, Nicolas M. Van Mieghem, Pieter C. Smits, Georgios J. Vlachojannis
Publikováno v:
American Heart Journal, 258, 17-26. Mosby Inc.
American heart journal, 258, 17-26. Mosby Inc.
American heart journal, 258, 17-26. Mosby Inc.
Background: The mechanisms underlying the increased risk of bleeding that female patients with ST-segment Elevation Myocardial Infarction (STEMI) exhibit, remains unclear. The present report assessed sex-related differences in response to pre-hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b863ef19a89040528bc0d38bd7c45cd
https://pure.eur.nl/en/publications/e548b0d0-e564-4335-a787-35626f8536bc
https://pure.eur.nl/en/publications/e548b0d0-e564-4335-a787-35626f8536bc
Autor:
Rosanne F. Vogel, Ronak Delewi, Pieter C. Smits, G. Montalescot, Nancy W.P.L. van der Waarden, Roberto Diletti, Jeroen Wilschut, Felix Zijlstra, Nicolas M. Van Mieghem, Dominick J. Angiolillo, Valeria Paradies, Rutger-Jan Nuis, Georgios J. Vlachojannis, Ria van Vliet, Dimitrios Alexopoulos, Mitchell W. Krucoff, Miguel E. Lemmert
Publikováno v:
JACC. Cardiovascular interventions, 14(12), 1323-1333. Elsevier Inc.
JACC: Cardiovascular Interventions, 14(12), 1323-1333. Elsevier Inc.
JACC: Cardiovascular Interventions, 14(12), 1323-1333. Elsevier Inc.
Objectives: This study sought to compare the pharmacodynamic effects of pre-hospitally administered P2Y12 inhibitor prasugrel in crushed versus integral tablet formulation in patients with ST-segment elevation myocardial infarction (STEMI) undergoing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c74155717c04e3999da1ae23d7df090a
http://www.scopus.com/inward/record.url?scp=85107739426&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85107739426&partnerID=8YFLogxK
Autor:
Rutger-Jan Nuis, Ronak Delewi, Georgios J. Vlachojannis, Jeroen Wilschut, Ria van Vliet, Roberto Diletti, Felix Zijlstra, Nicolas M. Van Mieghem, Dominick J. Angiolillo, Nancy W.P.L. van der Waarden, Valeria Paradies, Pieter C. Smits, Miguel E. Lemmert, Dimitrios Alexopoulos, Mitchell W. Krucoff, Rosanne F. Vogel, Gilles Montalescot
Publikováno v:
American Heart Journal
American Heart Journal, Elsevier, 2020, 224, pp.10-16. ⟨10.1016/j.ahj.2020.03.005⟩
American Heart Journal, 224, 10-16. Mosby Inc.
American Heart Journal, Elsevier, 2020, 224, pp.10-16. ⟨10.1016/j.ahj.2020.03.005⟩
American Heart Journal, 224, 10-16. Mosby Inc.
International audience; Background: Dual antiplatelet therapy constitutes the cornerstone of medical treatment in patients with ST elevation myocardial infarction (STEMI). However, oral antiplatelet agents, such as prasugrel or ticagrelor, are charac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac1cf25988bb109c185a464cf12deb8
https://doi.org/10.1016/j.ahj.2020.03.005
https://doi.org/10.1016/j.ahj.2020.03.005
Autor:
Nancy W.P.L. van der Waarden, Ronak Delewi, Roberto Diletti, Nicolas M. Van Mieghem, Pieter C. Smits, Miguel E. Lemmert, Georgios J. Vlachojannis, Ria van Vliet, Jeroen Wilschut, Dimitrios Alexopoulos, Felix Zijlstra, Gilles Montalescot, Rutger Jan Nuis, Rosanne F. Vogel, Valeria Paradies, Dominick J. Angiolillo
Publikováno v:
Journal of the American College of Cardiology. 78:B11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7638d82a1429cffbf7224e79fe76f51
https://doi.org/10.1016/j.jacc.2021.09.1371
https://doi.org/10.1016/j.jacc.2021.09.1371
Autor:
Miguel E. Lemmert, Valeria Paradies, Dominick J. Angiolillo, Dimitrios Alexopoulos, Georgios J. Vlachojannis, Ria van Vliet, Nancy W.P.L. van der Waarden, Felix Zijlstra, Ronak Delewi, Roberto Diletti, Nicolas M. Van Mieghem, Jeroen Wilschut, Rutger Jan Nuis, Gilles Montalescot, Rosanne F. Vogel, Pieter C. Smits
Publikováno v:
Journal of the American College of Cardiology. 78:B111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7a24ea26780f503606cebd966ab44ca
https://doi.org/10.1016/j.jacc.2021.09.1125
https://doi.org/10.1016/j.jacc.2021.09.1125
Autor:
Ria van Vliet, Martijn Meuwissen, Elvin Kedhi, Vincent Roolvink, Jan C.A. Hoorntje, Stéphane Cook, Alexander Zurakowski, Marco Togni, Christian Eek, Paweł Buszman, Martin van der Ent, Hans Wedel, Carl E. Schotborgh, Ronak Delewi, Clemens von Birgelen, Felix Zijlstra, Enrico Fabris, Niels van Royen
Publikováno v:
The BMJ
BMJ (Clinical research ed.), 363:k3793. British Medical Association
BMJ-British medical journal, 363:k3793. BMJ Publishing Group
BMJ. British Medical Journal (Online), 363, k3793
BMJ, 363:k3793. BMJ
BMJ. British Medical Journal (Online), 363, pp. k3793
BMJ (Clinical research ed.), 363:k3793. British Medical Association
BMJ-British medical journal, 363:k3793. BMJ Publishing Group
BMJ. British Medical Journal (Online), 363, k3793
BMJ, 363:k3793. BMJ
BMJ. British Medical Journal (Online), 363, pp. k3793
Objective To show that limiting dual antiplatelet therapy (DAPT) to six months in patients with event-free ST-elevation myocardial infarction (STEMI) results in a non-inferior clinical outcome versus DAPT for 12 months. Design Prospective, randomised
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f17cf0a91dac4df59e0581a52c0abf1c
http://europepmc.org/articles/PMC6167608
http://europepmc.org/articles/PMC6167608